PULM · Pulmatrix
AI read · Good for PULM
The AI's read
If the merger closes, Pulmatrix could gain a connection to a candidate aimed at protecting muscle. The findings came from aged mice, so they do not show whether the treatment helps people.
Eos SENOLYTIX shared new early research results for its product PTC-2105, which could affect investor interest in Pulmatrix.
Good for PULM
Pulmatrix's pending merger partner reported that PTC-2105 reduced muscle loss in aged mice. This is encouraging for Pulmatrix, but it is not yet evidence of benefit in people.
Get alerts for PULM
Follow Pulmatrix (PULM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for PULMFree on the App Store and Google Play, or on the web.